The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his wife and can admire his rich and diverse scientific work.
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources needed to speed up and further improve the quality of their outstanding research.
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their training or top up their degree programs.
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial and/or institutional partners, in order to serve the patient needs and for the benefit of the society, as well as to contribute to sustainability of the Institut Pasteur’s resources.
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study and traineeship fellowships are available to scientists. Alongside training, dynamism and attractiveness of RIIP will result in the creation of 4-year group for the young researchers.
Procter & Gamble And Institut Pasteur Announce A Joint Collaboration To Develop A New Therapeutic Approach For Asthma
Procter & Gamble Pharmaceuticals (P&GP), a subsidiary of The Procter & Gamble Co. (NYSE: PG), and Institut Pasteur today announced an agreement under which P&GP will develop and seek market authorization for drug candidate EFD, a new type of immuno-modulator for the treatment of asthma and other allergic disorders, stemming from a joint research collaboration between Institut Pasteur and Procter & Gamble in France.
Paris, september 30, 2004
Asthma is estimated to affect around 200 million people worldwide and can sometimes be a severe and potentially fatal disease. The prevalence of the disease is increasing, especially among children. Today there is no cure for asthma.
In pre-clinical models, EFD inhibited allergen-induced airway hyperresponsiveness by regulating the immune response, and it inhibited the release of cytokines and cells associated with allergies for more than a month. If fully successful in clinical trials and approved by regulatory bodies, EFD could offer patients a breakthrough prophylactive treatment for their asthma attacks.
Under the agreement, Institut Pasteur has granted P&GP an exclusive worldwide license to develop, manufacture, and commercialize EFD. P&GP will begin the pre-clinical evaluation of EFD for the treatment of asthma.
About Institut Pasteur
Institut Pasteur is a non-profit private foundation which contributes to the prevention and treatment of disease through research, education, and public health activities, in France and throughout the world. On its campus in Paris, it comprises more than 2,500 staff in 12 scientific departments, made up of more than 130 specialist units and research laboratories dealing with more than half of all infectious diseases, and others working in particular in the fields of immunology, neuro-sciences, cancers, and genetics. The Institut Pasteur has a world-wide reputation for its ground-breaking research on infectious agents, immunology, molecular biology, and for the discovery of the AIDS virus in 1983, and its scientists have been distinguished with eight Nobel prizes and a great number of other international prizes. www.pasteur.fr
About Procter and Gamble
Two billion times a day, P&G brands touch the lives of people around the world. The company has one of the largest and strongest portfolios of trusted, quality brands, including Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Bounty®, Pringles®, Folgers®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Actonel®, Olay® and Clairol Nice 'n Easy®. The P&G community consists of nearly 98,000 employees working in almost 80 countries worldwide including 24,000 people in 17 countries in Western Europe. Please visit www.pg.com for the latest news and in-depth information about P&G and its brands.